Should doctors ‘Google’ their patients?
March 12th 2015With the vast of information available online these days, it is only natural to want to search via ‘Google’ a past or current love, or even a potential employer to find out more about them. Patients also tend to search the Internet for physician recommendations-or negative comments-before choosing the right doctor for their ailment.But do physicians do the same for their patients? More importantly, is that even an acceptable practice?
Managing the dissatisfied multifocal IOL patient
March 10th 2015Implant exchange in multifocal IOL recipients unhappy with their vision is better performed sooner rather than later. It is even better to avoid the exchange whenever possible by identifying and addressing a treatable cause for the patient’s complaints.The best strategy of all is to prevent dissatisfaction in the first place by attention to patient selection and preoperative management, said Stephen G. Slade, MD.
Ophthalmologists’ role key to mitigating burden of diabetic eye disease
March 1st 2015Preserving vision in patients with diabetes requires ophthalmologists to be aware of the importance of reinforcing preventive strategies, maintaining communication with internists/diabetologists, and keeping up to date with current treatment approaches.
Anti-VEGF agent therapy rivals laser for macular edema in BRVO
March 1st 2015Patients treated with aflibercept intravitreal injections for macular edema associated with branch retinal vein occlusion had a significantly greater decrease in central retinal thickness and significantly greater improvement in vision compared with laser at the end of the 52-week VIBRANT trial.
Switching treatments for wet AMD poses numerous complexities
March 1st 2015Studies that focus on switching treatments for exudative age-related macular degeneration may represent more real-life scenarios. However, future prospective studies with predetermined switching criteria and follow-up are needed.
Genotype influences response to AREDS formulation
March 1st 2015An analysis of independent data published in AREDS Report 38 shows that the response of patients with moderate to advanced age-related macular degeneration (AMD) to treatment with zinc or the Age-Related Eye Disease Study (AREDS) formulation varied substantially based on genotype.